Renaissance Technologies
NVNO

Renaissance Technologies’s enVVeno Medical NVNO Stock Holding History

Renaissance Technologies’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,466
Closed -$16.5K – 3551
2025
Q4 		$16.5K Buy
1,466
+632
+76% +$12.3K ﹤0.01% 3156
2025
Q3 		$26.5K Buy
834
+448
+116% +$45.8K ﹤0.01% 3412
2025
Q2 		$53.9K Buy
+386
New +$45.6K ﹤0.01% 3385
2023
Q3 		– Sell
-336
Closed -$36K – 3961
2023
Q2 		$36K Buy
+336
New +$43.6K ﹤0.01% 3672
2022
Q1 		– Sell
-409
Closed -$94K – 4352
2021
Q4 		$94K Buy
+409
New +$115K ﹤0.01% 3690
2020
Q3 		– Sell
-309
Closed -$104K – 3583
2020
Q2 		$104K Buy
+309
New +$102K ﹤0.01% 3271

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies's NVNO Position: Q1 2026 in Review

Renaissance Technologies sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 1,466 shares — an estimated $16.5K sold.

Renaissance Technologies first reported a position in NVNO in Q2 2020 and held it in 6 quarters. The position peaked at $104K in Q2 2020. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Renaissance Technologies reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • Renaissance Technologies sold 1,466 enVVeno Medical shares in Q1 2026, an estimated $16.5K.
  • Renaissance Technologies first reported a position in enVVeno Medical in Q2 2020 and held it in 6 quarters.
  • Renaissance Technologies's enVVeno Medical position peaked at $104K in Q2 2020.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.